SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
Stem Cells Ease Stroke-Like Brain Damage in Mice, Tulane University’s Center for Gene Therapy Study
September 16, 2008
 · 
1 min read
Drug Development
Drug Reverses Huntington’s Symptoms In Mice, The Scripps Research Institute Study
September 16, 2008
 · 
1 min read
Drug Development
Immaturity Of The Brain May Cause Schizophrenia, Fujita Health University, National Institute for Physiological Sciences (NIPS), and Kyoto University Study
September 11, 2008
 · 
1 min read
Drug Development
Cortisol And Fatty Liver: Researchers Find Cause Of Severe Metabolic Disorders, German Cancer Research Center (DKFZ)
September 10, 2008
 · 
1 min read
Drug Development
New Methods Identify And Manipulate ‘Newborn’ Cells In Animal Model Of Parkinson’s Disease, Cedars-Sinai and Lund University Study
September 5, 2008
 · 
1 min read
Drug Development
Chemical in Plastic Is Connected to Health Problems in Monkeys, Yale University School Of Medicine Study
September 4, 2008
 · 
1 min read
Drug Development
‘Knockout’ Rats Could Aid Study Of Psychiatric Illness
September 3, 2008
 · 
1 min read
Drug Development
Continuous Brain Cell Generation Key To Learning And Memory, Kyoto University Study
September 2, 2008
 · 
1 min read
Drug Development
Antidepressants Need New Nerve Cells To Be Effective, University of Texas Southwestern Medical Center Researchers Find
August 29, 2008
 · 
1 min read
Drug Development
Variant Of Mad Cow Disease May Be Transmitted By Blood Transfusions, According To Animal Study -- American Society of Hematology
August 29, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
CODA Biotherapeutics’ Chemogenetic Gene Therapy Platform Can Control Focal Seizures in vivo
December 7, 2021
 · 
3 min read
Drug Development
QurAlis Presents New Data Confirming Role of STATHMIN-2 in Neuronal Disease Biology at 32nd International Symposium on ALS/MND
December 7, 2021
 · 
5 min read
Drug Development
Preclinical Studies Demonstrate Sotrovimab Retains Activity Against the Full Combination of Mutations in the Spike Protein of the Omicron SARS-CoV-2 Variant
December 7, 2021
 · 
17 min read
Drug Development
Taysha Gene Therapies Announces Late-Breaking Abstract and Poster Presentation on Positive Preclinical Data For TSHA-105 Demonstrating Therapeutic Potential for the Treatment of Epilepsy Caused by SLCA13A5 Deficiency
December 6, 2021
 · 
6 min read
Drug Development
Bsense Announces Positive Topline Proof-of-Concept Preclinical Data that Supports the Development in Additional Sensory Hyperexcitability Related Disorders
December 6, 2021
 · 
5 min read
Drug Development
Tumorad(R) Shows Good Safety in Preclinical Studies
December 6, 2021
 · 
2 min read
Drug Development
Neurona Therapeutics to Present New Preclinical Data and Clinical Trial Plans for Lead Neural Cell Therapy Program, NRTX-1001, at the Annual Meeting of the American Epilepsy Society
December 3, 2021
 · 
4 min read
Drug Development
cbdMD Therapeutics Announces Human Clinical Study In Collaboration With the University of South Carolina
December 3, 2021
 · 
4 min read
Drug Development
Aclaris Therapeutics Announces Publication of Preclinical Research of Zunsemetinib in Pancreatic Cancer in Science Translational Medicine
December 3, 2021
 · 
4 min read
Drug Development
FSD Pharma Unveils Videos Demonstrating Positive Effects of Lucid-MS in Treating Multiple Sclerosis in Pre-Clinical Models (Mouse Models)
December 2, 2021
 · 
6 min read
Drug Development
Preclinical Data Demonstrate Sotrovimab Retains Activity Against Key Omicron Mutations, New SARS-CoV-2 Variant
December 2, 2021
 · 
17 min read
Drug Development
Rubius Therapeutics to Host Virtual Preclinical Pipeline and Platform Technology Day on December 16, 2021
December 1, 2021
 · 
2 min read
Drug Development
Cocrystal Pharma Presents Preclinical Data from COVID-19 Antiviral Programs and Outlines Near-Term Clinical Plans at the World Antiviral Congress 2021
December 1, 2021
 · 
6 min read
Drug Development
Navrogen Announces Publication of Its Block-Removed Immunoglobulin Technology (BRITE) to Optimize Rituximab Activity in Humoral Immunosuppressed Cancers
November 30, 2021
 · 
2 min read
Drug Development
NLS Pharmaceutics Announces Preclinical Results Confirming the Potential Benefit and Safety Profile of NLS-4 for Circadian Rhythm Dysregulation and Chronic Fatigue Syndrome in Long-Covid Model
November 30, 2021
 · 
7 min read
Drug Development
Data on Naptumomab Estafenatox (NAP) Enhancing CAR-T cells Potency Presented by NeoTX at SITC 2021 Annual Meeting
November 30, 2021
 · 
2 min read
Drug Development
Biomica Reports Positive Results from Pre-Clinical Studies in its Inflammatory Bowel Disease (IBD) Program
November 30, 2021
 · 
7 min read
Drug Development
PharmaCyte Biotech Launches Malignant Ascites Program with Commencement of Pivotal Preclinical Study
November 30, 2021
 · 
4 min read
Drug Development
Adial Pharmaceuticals Announces Positive Pre-Clinical Data for PNV2 as a Drug Candidate for Triple Negative Breast CancerPNV2 demonstrates reduction of metastases in animal model
November 29, 2021
 · 
7 min read
Drug Development
eFFECTOR Therapeutics Announces Publication of Zotatifin Preclinical Data in Frontiers in Oncology
November 24, 2021
 · 
5 min read
Load More